Neil W Gibson
CIK 1555918 · Chief Scientific Officer · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
36
Lifetime Open-Market Net
-$2.42M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| STTK | Director | — | $4.94 | — | $0 | 7 | 2026-06-02 |
| TIL | Director | — | $7.92 | — | $0 | 5 | 2025-05-29 |
| TCR2 THERAPEUTICS INC. (TCRR) Delisted | Director | 493,791 | $1.48 | $730.8K | -$525.2K | 8 | 2023-06-01 |
| Regulus Therapeutics Inc. (RGLS) Delisted | Chief Scientific Officer | 8,655 | $8.16 | $70.6K | -$1.90M | 16 | 2015-01-30 |
Recent Filings · Page 3 of 4
36 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-01-30 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −80,000 | -$1.44M | EDGAR |
| 2014-12-04 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-12-01 | Regulus Therapeutics Inc. (RGLS) Delisted | Mixed | — | -$43.9K | EDGAR |
| 2014-10-31 | Regulus Therapeutics Inc. (RGLS) Delisted | Mixed | — | -$43.9K | EDGAR |
| 2014-10-24 | Regulus Therapeutics Inc. (RGLS) Delisted | Mixed | — | -$41.9K | EDGAR |
| 2014-10-22 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-09-15 | Regulus Therapeutics Inc. (RGLS) Delisted | Mixed | — | -$26.3K | EDGAR |
| 2014-07-02 | Regulus Therapeutics Inc. (RGLS) Delisted | Mixed | — | -$15.9K | EDGAR |
| 2014-03-07 | Regulus Therapeutics Inc. (RGLS) Delisted | Mixed | — | -$24.1K | EDGAR |
| 2014-02-07 | Regulus Therapeutics Inc. (RGLS) Delisted | Mixed | +30,000 | -$64.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.